Patient

P2B-137

completed Phase II

A Multicenter, Randomized, Open-Label Phase 2b Study to Investigate the Preliminary Efficacy and Safety of INNO-206 (Doxorubicin-EMCH) Compared to Doxorubicin in Subjects With Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcoma · CTRC Institute for Drug Development, University of Texas (San Antonio, TX) (Dr. Muller)

consented 2013-07-17

CTRC Institute for Drug Development, University of Texas (San Antonio, TX)

Adverse events

Serious AEs

Open data queries

Luna dropout signal

—

not on Luna

Adverse events 3

severe assessed 2013-10-24

Grade 3 hypokalaemia with onset in cycle 4 (2013-10-24); assessed as not related to study drug (not related); resolved 2013-11-02; action: drug interrupted.

moderate assessed 2013-10-02

Grade 2 anaemia with onset in cycle 3 (2013-10-02); assessed as related to study drug (probable); resolved 2013-10-23.

mild assessed 2013-08-23

Grade 1 nausea with onset in cycle 2 (2013-08-23); assessed as not related to study drug (not related); resolved 2013-08-25.

Data queries 0

No data queries

The CDM sweep raises queries on inconsistent fields.

Luna engagement

This participant doesn't use Luna

Invite them from the site to track mood, adherence and check-ins.

Open Luna users